SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jee Hae Kang, Minkyung Lee, Young Hoon Ryu, Chul Hyoung Lyoo, Chul Hoon Kim, Kyo Chul Lee, Tae Hyun Choi, Jae Yong Choi, [18F]FPEB and [18F]FDEGPECO comparative study of mGlu5 quantification in rodent brain, Applied Radiation and Isotopes, 2015, 98, 103

    CrossRef

  2. You have free access to this content2
    Dominik P. Kiser, Olga Rivero, Klaus-Peter Lesch, Annual Research Review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing – unveiling the dark matter, Journal of Child Psychology and Psychiatry, 2015, 56, 3
  3. 3
    Niamh Devitt, Louise Gallagher, Richard Reilly, Autism Spectrum Disorder (ASD) and Fragile X Syndrome (FXS): Two Overlapping Disorders Reviewed through Electroencephalography—What Can be Interpreted from the Available Information?, Brain Sciences, 2015, 5, 2, 92

    CrossRef

  4. 4
    Mary Phillips, Lucas Pozzo-Miller, Dendritic spine dysgenesis in autism related disorders, Neuroscience Letters, 2015,

    CrossRef

  5. 5
    Derek W. Bailey, Steven Lunt, Adrienne Lipka, Milt G. Thomas, Juan F. Medrano, Angela Cánovas, Gonzalo Rincon, Mitch B. Stephenson, Delyn Jensen, Genetic Influences on Cattle Grazing Distribution: Association of Genetic Markers with Terrain Use in Cattle, Rangeland Ecology & Management, 2015, 68, 2, 142

    CrossRef

  6. 6
    Timothy D. Folsom, Paul D. Thuras, S. Hossein Fatemi, Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders, Schizophrenia Research, 2015, 165, 2-3, 201

    CrossRef

  7. 7
    Hansen Wang, Sandipan Pati, Lucas Pozzo-Miller, Laurie C. Doering, Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes, Frontiers in Cellular Neuroscience, 2015, 9,

    CrossRef

  8. 8
    Marion Agnes Emma André, Onur Güntürkün, Denise Manahan-Vaughan, The metabotropic glutamate receptor, mGlu5, is required for extinction learning that occurs in the absence of a context change, Hippocampus, 2015, 25, 2
  9. 9
    Sang Woo Kim, Kyoung Joo Cho, Activity-dependent alterations in the sensitivity to BDNF-TrkB signaling may promote excessive dendritic arborization and spinogenesis in fragile X syndrome in order to compensate for compromised postsynaptic activity, Medical Hypotheses, 2014, 83, 4, 429

    CrossRef

  10. 10
    Aubin Michalon, Andreas Bruns, Céline Risterucci, Michael Honer, Theresa M. Ballard, Laurence Ozmen, Georg Jaeschke, Joseph G. Wettstein, Markus von Kienlin, Basil Künnecke, Lothar Lindemann, Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice, Biological Psychiatry, 2014, 75, 3, 189

    CrossRef

  11. 11
    Regina Waltes, Eftichia Duketis, Michael Knapp, Richard J. L. Anney, Guillaume Huguet, Sabine Schlitt, Tomasz A. Jarczok, Michael Sachse, Laura M. Kämpfer, Tina Kleinböck, Fritz Poustka, Sven Bölte, Gabriele Schmötzer, Anette Voran, Ellen Huy, Jobst Meyer, Thomas Bourgeron, Sabine M. Klauck, Christine M. Freitag, Andreas G. Chiocchetti, Common variants in genes of the postsynaptic FMRP signalling pathway are risk factors for autism spectrum disorders, Human Genetics, 2014, 133, 6, 781

    CrossRef

  12. 12
    Brian Hon-Yin Chung, Victoria Qinchen Tao, Winnie Wan-Yee Tso, Copy number variation and autism: New insights and clinical implications, Journal of the Formosan Medical Association, 2014, 113, 7, 400

    CrossRef

  13. 13
    Baltazar Gomez-Mancilla, Elizabeth Berry-Kravis, Randi Hagerman, Florian von Raison, George Apostol, Mike Ufer, Fabrizio Gasparini, Sébastien Jacquemont, Development of mavoglurant and its potential for the treatment of fragile X syndrome, Expert Opinion on Investigational Drugs, 2014, 23, 1, 125

    CrossRef

  14. 14
    William B. Mathews, Hiroto Kuwabara, Kirstie Stansfield, Heather Valentine, Mohab Alexander, Anil Kumar, John Hilton, Robert F. Dannals, Dean F. Wong, Fabrizio Gasparini, Dose-dependent, saturable occupancy of the metabotropic glutamate subtype 5 receptor by fenobam as measured with [11C]ABP688 PET imaging, Synapse, 2014, 68, 12
  15. 15
    Simona D’Antoni, Michela Spatuzza, Carmela M. Bonaccorso, Sebastiano A. Musumeci, Lucia Ciranna, Ferdinando Nicoletti, Kimberly M. Huber, Maria Vincenza Catania, Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism, Neuroscience & Biobehavioral Reviews, 2014, 46, 228

    CrossRef

  16. 16
    Gordon X. Wang, Stephen J Smith, Philippe Mourrain, Fmr1 KO and Fenobam Treatment Differentially Impact Distinct Synapse Populations of Mouse Neocortex, Neuron, 2014, 84, 6, 1273

    CrossRef

  17. 17
    S. Hossein Fatemi, Timothy D. Folsom, GABA receptor subunit distribution and FMRP–mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism, Schizophrenia Research, 2014,

    CrossRef

  18. 18
    Aimee V. Franklin, Margaret K. King, Valle Palomo, Ana Martinez, Lori L. McMahon, Richard S. Jope, Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice, Biological Psychiatry, 2014, 75, 3, 198

    CrossRef

  19. You have free access to this content19
    Daman Kumari, Aditi Bhattacharya, Jeffrey Nadel, Kristen Moulton, Nicole M. Zeak, Anne Glicksman, Carl Dobkin, David J. Brick, Philip H. Schwartz, Carolyn B. Smith, Eric Klann, Karen Usdin, Identification of Fragile X Syndrome Specific Molecular Markers in Human Fibroblasts: A Useful Model to Test the Efficacy of Therapeutic Drugs, Human Mutation, 2014, 35, 12
  20. 20
    Tao Chen, Jing-Shan Lu, Qian Song, Ming-Gang Liu, Kohei Koga, Giannina Descalzi, Yun-Qing Li, Min Zhuo, Pharmacological Rescue of Cortical Synaptic and Network Potentiation in a Mouse Model for Fragile X Syndrome, Neuropsychopharmacology, 2014, 39, 8, 1955

    CrossRef

  21. 21
    Karen Usdin, Bruce E. Hayward, Daman Kumari, Rachel A. Lokanga, Nicholas Sciascia, Xiao-Nan Zhao, Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders, Frontiers in Genetics, 2014, 5,

    CrossRef

  22. 22
    Alberto Lazarowski, Liliana Czornyj, Genetics of Epilepsy and Refractory Epilepsy, Colloquium Series on The Genetic Basis of Human Disease, 2013, 2, 1, 1

    CrossRef

  23. 23
    Craig A. Erickson, Logan K. Wink, Balmiki Ray, Maureen C. Early, Elizabeth Stiegelmeyer, Lauren Mathieu-Frasier, Vanessa Patrick, Debomoy K. Lahiri, Christopher J. McDougle, Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome, Psychopharmacology, 2013, 228, 1, 75

    CrossRef

  24. 24
    Jill L. Silverman, Brooke A. Babineau, Chicora F. Oliver, Michael N. Karras, Jacqueline N. Crawley, Influence of stimulant-induced hyperactivity on social approach in the BTBR mouse model of autism, Neuropharmacology, 2013, 68, 210

    CrossRef

  25. 25
    Suhail Asrar, Zhengping Jia, Molecular mechanisms coordinating functional and morphological plasticity at the synapse: Role of GluA2/N-cadherin interaction-mediated actin signaling in mGluR-dependent LTD, Cellular Signalling, 2013, 25, 2, 397

    CrossRef

  26. 26
    You Yang, Chunhua Pan, Role of metabotropic glutamate receptor 7 in autism spectrum disorders: A pilot study, Life Sciences, 2013, 92, 2, 149

    CrossRef

  27. 27
    Felice Iasevoli, Carmine Tomasetti, Andrea de Bartolomeis, Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases, Neurochemical Research, 2013, 38, 1, 1

    CrossRef

  28. 28
    D. Inta, M.A. Vogt, A. Luoni, D. Filipović, J.M. Lima-Ojeda, N. Pfeiffer, F. Gasparini, M.A. Riva, P. Gass, Significant increase in anxiety during aging in mGlu5 receptor knockout mice, Behavioural Brain Research, 2013, 241, 27

    CrossRef

  29. 29
    Annamaria Jakab, Serge Winter, Marc Raccuglia, Frank Picard, Swati Dumitras, Ralph Woessner, Sanket Mistry, Jayraj Chudasama, Swati Guttikar, Olivier Kretz, Validation of an LC-MS/MS method for the quantitative determination of mavoglurant (AFQ056) in human plasma, Analytical and Bioanalytical Chemistry, 2013, 405, 1, 215

    CrossRef

  30. 30
    Gene J. Blatt, The Neuroscience of Autism Spectrum Disorders, 2013,

    CrossRef

  31. 31
    Evdokia Anagnostou, Caitlyn McKeever, Azadeh Kushki, The Neuroscience of Autism Spectrum Disorders, 2013,

    CrossRef

  32. 32
    James C McGann, Daniel T Lioy, Gail Mandel, Astrocytes conspire with neurons during progression of neurological disease, Current Opinion in Neurobiology, 2012, 22, 5, 850

    CrossRef

  33. 33
    Lawrence Scahill, James T. McCracken, Karen Bearss, Fay Robinson, Eric Hollander, Bryan King, Joel Bregman, Lin Sikich, Kimberly Dukes, Lisa Sullivan, Evdokia Anagnostou, Craig Donnelly, Young-Shin Kim, Louise Ritz, Deborah Hirtz, Ann Wagner, Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders, Journal of Autism and Developmental Disorders, 2012, 42, 3, 432

    CrossRef

  34. 34
    Deborah Hall, Flora Tassone, Olga Klepitskaya, Maureen Leehey, Fragile X–associated tremor ataxia syndrome in FMR1 gray zone allele carriers, Movement Disorders, 2012, 27, 2
  35. 35
    Paromita Roy Choudhury, Sanjukta Lahiri, Usha Rajamma, Glutamate mediated signaling in the pathophysiology of autism spectrum disorders, Pharmacology Biochemistry and Behavior, 2012, 100, 4, 841

    CrossRef

  36. 36
    Greg C. Carlson, Glutamate receptor dysfunction and drug targets across models of autism spectrum disorders, Pharmacology Biochemistry and Behavior, 2012, 100, 4, 850

    CrossRef

  37. 37
    Hansen Wang, Laurie C. Doering, Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders, Neural Plasticity, 2012, 2012, 1

    CrossRef

  38. 38
    Agnieszka Pałucha-Poniewiera, Andrzej Pilc, Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, 39, 1, 102

    CrossRef

  39. 39
    Da Shi, Su Xu, Jaylyn Waddell, Susanna Scafidi, Steven Roys, Rao P. Gullapalli, Mary C. McKenna, Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice, Journal of Neurochemistry, 2012, 123, 6
  40. 40
    Saul S. Siller, Kendal Broadie, Matrix Metalloproteinases and Minocycline: Therapeutic Avenues for Fragile X Syndrome, Neural Plasticity, 2012, 2012, 1

    CrossRef

  41. 41
    Sharon Smile, Evdokia Anagnostou, New Models for Considering the Role of Medication in the Treatment and Elucidation of the Etiology of Autism, Current Psychiatry Reports, 2012, 14, 6, 726

    CrossRef

  42. 42
    Mark J. Niciu, Benjamin Kelmendi, Gerard Sanacora, Overview of glutamatergic neurotransmission in the nervous system, Pharmacology Biochemistry and Behavior, 2012, 100, 4, 656

    CrossRef

  43. 43
    Stephanie M. Sansone, Keith F. Widaman, Scott S. Hall, Allan L. Reiss, Amy Lightbody, Walter E. Kaufmann, Elizabeth Berry-Kravis, Ave Lachiewicz, Elaine C. Brown, David Hessl, Psychometric Study of the Aberrant Behavior Checklist in Fragile X Syndrome and Implications for Targeted Treatment, Journal of Autism and Developmental Disorders, 2012, 42, 7, 1377

    CrossRef

  44. 44
    C. Henderson, L. Wijetunge, M. N. Kinoshita, M. Shumway, R. S. Hammond, F. R. Postma, C. Brynczka, R. Rush, A. Thomas, R. Paylor, S. T. Warren, P. W. Vanderklish, P. C. Kind, R. L. Carpenter, M. F. Bear, A. M. Healy, Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen, Science Translational Medicine, 2012, 4, 152, 152ra128

    CrossRef

  45. 45
    Vaishali A. Kulkarni, Bonnie L. Firestein, The dendritic tree and brain disorders, Molecular and Cellular Neuroscience, 2012, 50, 1, 10

    CrossRef

  46. 46
    C. Kubera, A.L. Hernandez, V. Heng, A. Bordey, Transient mGlu5R inhibition enhances the survival of granule cell precursors in the neonatal cerebellum, Neuroscience, 2012, 219, 271

    CrossRef

  47. 47
    Evdokia Anagnostou, Translational medicine: Mice and men show the way, Nature, 2012, 491, 7423, 196

    CrossRef

  48. 48
    Jocelyn J. LeBlanc, Michela Fagiolini, Autism: A “Critical Period” Disorder?, Neural Plasticity, 2011, 2011, 1

    CrossRef

  49. 49
    JC Darnell, Defects in translational regulation contributing to human cognitive and behavioral disease, Current Opinion in Genetics & Development, 2011, 21, 4, 465

    CrossRef

  50. 50
    Tanya L. Wallace, Theresa M. Ballard, Bruno Pouzet, Wim J. Riedel, Joseph G. Wettstein, Drug targets for cognitive enhancement in neuropsychiatric disorders, Pharmacology Biochemistry and Behavior, 2011, 99, 2, 130

    CrossRef

  51. 51
    Scott M. Paluszkiewicz, Brandon S. Martin, Molly M. Huntsman, Fragile X Syndrome: The GABAergic System and Circuit Dysfunction, Developmental Neuroscience, 2011, 33, 5, 349

    CrossRef

  52. 52
    Silvia Bernardi, Evdokia Anagnostou, Jun Shen, Alexander Kolevzon, Joseph D. Buxbaum, Eric Hollander, Patrick R. Hof, Jin Fan, In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism, Brain Research, 2011, 1380, 198

    CrossRef

  53. 53
    Christine DeLorenzo, Matthew S. Milak, Kathleen G. Brennan, J. S. Dileep Kumar, J. John Mann, Ramin V. Parsey, In vivo positron emission tomography imaging with [11C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons, European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, 6, 1083

    CrossRef

  54. 54
    Christine DeLorenzo, J S Dileep Kumar, J John Mann, Ramin V Parsey, In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688, Journal of Cerebral Blood Flow & Metabolism, 2011, 31, 11, 2169

    CrossRef

  55. 55
    S. G. Popkirov, D. Manahan-Vaughan, Involvement of the Metabotropic Glutamate Receptor mGluR5 in NMDA Receptor-Dependent, Learning-Facilitated Long-Term Depression in CA1 Synapses, Cerebral Cortex, 2011, 21, 3, 501

    CrossRef

  56. You have free access to this content56
    S. Hossein Fatemi, Timothy D. Folsom, Rachel E. Kneeland, Stephanie B. Liesch, Metabotropic Glutamate Receptor 5 Upregulation in Children with Autism is Associated with Underexpression of Both Fragile X Mental Retardation Protein and GABAA Receptor Beta 3 in Adults with Autism, The Anatomical Record, 2011, 294, 10
  57. 57
    Lynda El-Hassar, Anna M. Hagenston, Lisa Bertetto D’Angelo, Mark F. Yeckel, Metabotropic glutamate receptors regulate hippocampal CA1 pyramidal neuron excitability via Ca2+ wave-dependent activation of SK and TRPC channels, The Journal of Physiology, 2011, 589, 13
  58. 58
    F. Nicoletti, J. Bockaert, G.L. Collingridge, P.J. Conn, F. Ferraguti, D.D. Schoepp, J.T. Wroblewski, J.P. Pin, Metabotropic glutamate receptors: From the workbench to the bedside, Neuropharmacology, 2011, 60, 7-8, 1017

    CrossRef

  59. 59
    Craig A. Erickson, Ning Weng, Ivan Jeanne Weiler, William T. Greenough, Kimberly A. Stigler, Logan K. Wink, Christopher J. McDougle, Open-label riluzole in fragile X syndrome, Brain Research, 2011, 1380, 264

    CrossRef

  60. 60
    S. Hossein Fatemi, Timothy D. Folsom, The role of fragile X mental retardation protein in major mental disorders, Neuropharmacology, 2011, 60, 7-8, 1221

    CrossRef

  61. 61
    Yuzo M. Chino, Adler's Physiology of the Eye, 2011,

    CrossRef

  62. 62
    Ozdem Erturk, Kaya Bilguvar, Baris Korkmaz, Yasar Bayri, Fatih Bayrakli, Zulfikar Arlier, Ali K. Ozturk, Cengiz Yalcinkaya, Beyhan Tuysuz, Matthew W. State, Murat Gunel, A patient with Duchenne muscular dystrophy and autism demonstrates a hemizygous deletion affecting Dystrophin, American Journal of Medical Genetics Part A, 2010, 152A, 4
  63. 63
    Mauro Maccarrone, Silvia Rossi, Monica Bari, Valentina De Chiara, Cinzia Rapino, Alessandra Musella, Giorgio Bernardi, Claudia Bagni, Diego Centonze, Abnormal mGlu 5 Receptor/Endocannabinoid Coupling in Mice Lacking FMRP and BC1 RNA, Neuropsychopharmacology, 2010, 35, 7, 1500

    CrossRef

  64. 64
    Jill L. Silverman, Mu Yang, Catherine Lord, Jacqueline N. Crawley, Behavioural phenotyping assays for mouse models of autism, Nature Reviews Neuroscience, 2010, 11, 7, 490

    CrossRef

  65. 65
    Craig A. Erickson, Jennifer E. Mullett, Christopher J. McDougle, Brief Report: Acamprosate in Fragile X Syndrome, Journal of Autism and Developmental Disorders, 2010, 40, 11, 1412

    CrossRef

  66. 66
    Y. Takayasu, K. Takeuchi, R. Kumari, M. V. L. Bennett, R. S. Zukin, A. Francesconi, Caveolin-1 knockout mice exhibit impaired induction of mGluR-dependent long-term depression at CA3-CA1 synapses, Proceedings of the National Academy of Sciences, 2010, 107, 50, 21778

    CrossRef

  67. 67
    B. Crespi, P. Stead, M. Elliot, Comparative genomics of autism and schizophrenia, Proceedings of the National Academy of Sciences, 2010, 107, suppl_1, 1736

    CrossRef

  68. 68
    Daniel C. Adusei, Laura K.K. Pacey, Duke Chen, David R. Hampson, Early developmental alterations in GABAergic protein expression in fragile X knockout mice, Neuropharmacology, 2010, 59, 3, 167

    CrossRef

  69. 69
    Christian Lüscher, Kimberly M. Huber, Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease, Neuron, 2010, 65, 4, 445

    CrossRef

  70. 70
    Christopher J. Yuskaitis, Marjelo A. Mines, Margaret K. King, J. David Sweatt, Courtney A. Miller, Richard S. Jope, Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome, Biochemical Pharmacology, 2010, 79, 4, 632

    CrossRef

  71. 71
    Graham L. Collingridge, Stephane Peineau, John G. Howland, Yu Tian Wang, Long-term depression in the CNS, Nature Reviews Neuroscience, 2010, 11, 7, 459

    CrossRef

  72. 72
    Daniel Coury, Medical treatment of autism spectrum disorders, Current Opinion in Neurology, 2010, 23, 2, 131

    CrossRef

  73. 73
    Joshua T. Kantrowitz, Daniel C. Javitt, N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?, Brain Research Bulletin, 2010, 83, 3-4, 108

    CrossRef

  74. 74
    Jill L Silverman, Seda S Tolu, Charlotte L Barkan, Jacqueline N Crawley, Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEP, Neuropsychopharmacology, 2010, 35, 4, 976

    CrossRef

  75. 75
    Myrrhe van Spronsen, Casper C. Hoogenraad, Synapse Pathology in Psychiatric and Neurologic Disease, Current Neurology and Neuroscience Reports, 2010, 10, 3, 207

    CrossRef

  76. 76
    Paul L. Greer, Rikinari Hanayama, Brenda L. Bloodgood, Alan R. Mardinly, David M. Lipton, Steven W. Flavell, Tae-Kyung Kim, Eric C. Griffith, Zachary Waldon, Rene Maehr, Hidde L. Ploegh, Shoaib Chowdhury, Paul F. Worley, Judith Steen, Michael E. Greenberg, The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc, Cell, 2010, 140, 5, 704

    CrossRef

  77. 77
    D. Harshad Bhatt, Shengxiang Zhang, Wen-Biao Gan, Dendritic Spine Dynamics, Annual Review of Physiology, 2009, 71, 1, 261

    CrossRef

  78. 78
    Randi J. Hagerman, FRAGILE X SYNDROME AND ASSOCIATED DISORDERS IN ADULTHOOD, CONTINUUM: Lifelong Learning in Neurology, 2009, 15, 32

    CrossRef

  79. You have free access to this content79
    A. Schneider, R.J. Hagerman, D. Hessl, Fragile X syndrome—From genes to cognition, Developmental Disabilities Research Reviews, 2009, 15, 4
  80. 80
    Weerasak Chonchaiya, Andrea Schneider, Randi J. Hagerman, Fragile X: A Family of Disorders, Advances in Pediatrics, 2009, 56, 1, 165

    CrossRef

  81. 81
    Liisa A. Tremere, Raphael Pinaud, mGluR5 is a central regulator of synaptic function and plasticity in the developing mouse barrel cortex, Journal of Biosciences, 2009, 34, 2, 161

    CrossRef

  82. 82
    D. Tropea, A. Van Wart, M. Sur, Molecular mechanisms of experience-dependent plasticity in visual cortex, Philosophical Transactions of the Royal Society B: Biological Sciences, 2009, 364, 1515, 341

    CrossRef

  83. 83
    Ami Citri, Gilberto Soler-Llavina, Samarjit Bhattacharyya, Robert C. Malenka, N-methyl-d-aspartate receptor- and metabotropic glutamate receptor-dependent long-term depression are differentially regulated by the ubiquitin-proteasome system, European Journal of Neuroscience, 2009, 30, 8
  84. 84
    Linda S Brady, Lois Winsky, Wayne Goodman, Mary Ellen Oliveri, Ellen Stover, NIMH Initiatives to Facilitate Collaborations Among Industry, Academia, and Government for the Discovery and Clinical Testing of Novel Models and Drugs for Psychiatric Disorders, Neuropsychopharmacology, 2009, 34, 1, 229

    CrossRef

  85. 85
    Craig A. Erickson, Jennifer E. Mullett, Christopher J. McDougle, Open-Label Memantine in Fragile X Syndrome, Journal of Autism and Developmental Disorders, 2009, 39, 12, 1629

    CrossRef

  86. 86
    David Hessl, Elizabeth Berry-Kravis, Lisa Cordeiro, Jennifer Yuhas, Edward M. Ornitz, Aaron Campbell, Elizabeth Chruscinski, Crystal Hervey, James M. Long, Randi J. Hagerman, Prepulse inhibition in fragile X syndrome: Feasibility, reliability, and implications for treatment, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2009, 150B, 4
  87. 87
    Maggie W Waung, Kimberly M Huber, Protein translation in synaptic plasticity: mGluR-LTD, Fragile X, Current Opinion in Neurobiology, 2009, 19, 3, 319

    CrossRef

  88. 88
    Michael K. Bird, Andrew J. Lawrence, The promiscuous mGlu5 receptor – a range of partners for therapeutic possibilities?, Trends in Pharmacological Sciences, 2009, 30, 12, 617

    CrossRef

  89. 89
    Marjorie Solomon, David Hessl, Sufen Chiu, Emily Olsen, Robert L. Hendren, Towards a Neurodevelopmental Model of Clinical Case Formulation, Psychiatric Clinics of North America, 2009, 32, 1, 199

    CrossRef

  90. 90
    Douglas W. Laube, Cosmetic Therapies in Obstetrics and Gynecology Practice: Putting a Toe in the Water?, Obstetrics & Gynecology, 2008, 112, 3, 704

    CrossRef

  91. 91
    Chris J. McBain, New directions in synaptic and network plasticity – a move away from NMDA receptor mediated plasticity, The Journal of Physiology, 2008, 586, 6
  92. 92
    Miao-Kun Sun, The quest for treatment of cognitive impairment: AMPA and mGlu5 receptor modulators, Expert Opinion on Therapeutic Patents, 2008, 18, 9, 999

    CrossRef

  93. 93
    Randi J. Hagerman, Fragile X Syndrome and Premutation-Associated Disorders,
  94. 94
    Lawrence D. Scahilll, Susan Boorin, Neurobiology and Neurophysiology of Behavioral/Psychiatric Disorders,